L04AG03 Natalizumab
ATC class of level 5 – chemical substance
This page lists the patient medication information or the product monograph for 2 drugs in this drug class.
- 2 prescription (Rx)
Active ingredient: Natalizumab – all drugs with this active ingredient, also in combination.
Place in the ATC system
- L Antineoplastic and immunomodulating agents 1,069 drugs
- L04 Immunosuppressants 246 drugs
- L04A Immunosuppressants 246 drugs
- L04AG03 Natalizumab 2 drugs
- L04A Immunosuppressants 246 drugs
- L04 Immunosuppressants 246 drugs
Drugs in the class
| Drug | Rx or OTC |
|---|---|
| Tyruko | prescription (Rx) |
| Tysabri | prescription (Rx) |
Other classes of the same level
- L04AG02 Efalizumab 1 drug
- L04AG04 Belimumab 2 drugs
- L04AG05 Vedolizumab 1 drug
- L04AG06 Alemtuzumab 2 drugs
- L04AG08 Ocrelizumab 1 drug
- L04AG10 Inebilizumab 1 drug
- L04AG13 Teprotumumab 1 drug
Other names of the drug class
- German (Switzerland): L04AG03 Natalizumab
- French (Switzerland): L04AG03 Natalizumab
- Italian (Switzerland): L04AG03 Natalizumab
Sources
- Patient medication information and product monographs: Health Canada, Drug Product Database
- Active ingredients, ATC codes and Rx or OTC status: Health Canada, Drug Product Database
- World Health Organization (WHO): ATC/DDD system, class L04AG03
Ask your doctor or pharmacist for advice.